Your browser doesn't support javascript.
loading
EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer.
Roman-Canal, Berta; Moiola, Cristian Pablo; Gatius, Sònia; Bonnin, Sarah; Ruiz-Miró, Maria; González, Esperanza; González-Tallada, Xavier; Llordella, Ivanna; Hernández, Isabel; Porcel, José M; Gil-Moreno, Antonio; Falcón-Pérez, Juan M; Ponomarenko, Julia; Matias-Guiu, Xavier; Colas, Eva.
Afiliación
  • Roman-Canal B; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain. bertaromancanal@gmail.com.
  • Moiola CP; Department of Pathology, University Hospital of Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Spain. bertaromancanal@gmail.com.
  • Gatius S; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), CIBERONC, 08035 Barcelona, Spain. bertaromancanal@gmail.com.
  • Bonnin S; Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain. bertaromancanal@gmail.com.
  • Ruiz-Miró M; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain. cristian.pablo@vhir.org.
  • González E; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), CIBERONC, 08035 Barcelona, Spain. cristian.pablo@vhir.org.
  • González-Tallada X; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain. sgatius.lleida.ics@gencat.cat.
  • Llordella I; Centre for Genomic Regulation (CRG), The Barcelona Institute or Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain. sarah.bonnin@crg.eu.
  • Hernández I; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain. mruiz@irblleida.cat.
  • Porcel JM; Exosomes Laboratory and Metabolomics Platform. CIC bioGUNE, CIBEREHD Bizkaia Technology Park, 48160 Derio, Spain. egonzalez@cicbiogune.es.
  • Gil-Moreno A; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain. fjgonzalezt.lleida.ics@gencat.cat.
  • Falcón-Pérez JM; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain. ivanna.llordella@gmail.com.
  • Ponomarenko J; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain. Isabelmedico@gmail.com.
  • Matias-Guiu X; Pleural Medicine Unit, Arnau de Vilanova University Hospital, Cancer Biomarker Group, IRBLleida, 25198 Lleida, Spain. jporcelp@yahoo.es.
  • Colas E; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), CIBERONC, 08035 Barcelona, Spain. antonioimma@yahoo.es.
Cancers (Basel) ; 11(6)2019 Jun 18.
Article en En | MEDLINE | ID: mdl-31216648
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: España